DK0817852T3 - Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein - Google Patents

Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Info

Publication number: DK0817852T3
Authority: DK; Denmark
Prior art keywords: protein; human papillomavirus; synthetic; hpv6; hybrid
Prior art date: 1995-03-30

Application number

DK96912467T

Other languages

Danish (da)

English (en)

Inventor

Kathrin U Jansen

Hugh A George

Kathryn J Hofmann

Joseph G Joyce

Michael P Neeper

E Dale Lehman

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

1996-03-26

Publication date

2003-11-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-03-26 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2003-11-24 Application granted granted Critical

2003-11-24 Publication of DK0817852T3 publication Critical patent/DK0817852T3/da

Links

101000642125 Human papillomavirus 11 Major capsid protein L1 Proteins 0.000 title abstract 2
108020004414 DNA Proteins 0.000 abstract 1
102000053602 DNA Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

DK96912467T 1995-03-30 1996-03-26 Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein DK0817852T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US41357295A	1995-03-30	1995-03-30
US41357195A	1995-03-30	1995-03-30
PCT/US1996/004117 WO1996030520A2 (fr)	1995-03-30	1996-03-26	Adn de synthese hybride hpv6/11 l1 codant pour des proteines de papillomavirus humain de type 11 l1

Publications (1)

Publication Number	Publication Date
DK0817852T3 true DK0817852T3 (da)	2003-11-24

Family

ID=27022236

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96912467T DK0817852T3 (da)	1995-03-30	1996-03-26	Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Country Status (21)

Country	Link
US (1)	US6159729A (fr)
EP (1)	EP0817852B1 (fr)
JP (1)	JP3918877B2 (fr)
KR (1)	KR100441477B1 (fr)
CN (1)	CN1154732C (fr)
AT (1)	ATE247712T1 (fr)
AU (1)	AU708111B2 (fr)
CZ (1)	CZ291375B6 (fr)
DE (1)	DE69629556T2 (fr)
DK (1)	DK0817852T3 (fr)
EA (1)	EA000969B1 (fr)
ES (1)	ES2203691T3 (fr)
HU (1)	HU228490B1 (fr)
IL (1)	IL117591A0 (fr)
NO (1)	NO320086B1 (fr)
NZ (1)	NZ306663A (fr)
PL (1)	PL183299B1 (fr)
PT (1)	PT817852E (fr)
SK (1)	SK283998B6 (fr)
WO (1)	WO1996030520A2 (fr)
ZA (1)	ZA962526B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU694269B2 (en) *	1994-09-22	1998-07-16	Merck Sharp & Dohme Corp.	Dna encoding human papillomavirus type 6a
GB9621091D0 (en)	1996-10-09	1996-11-27	Fondation Pour Le Perfectionem	Attenuated microorganisms strains and their uses
IL132201A0 (en) *	1997-04-08	2001-03-19	Merck & Co Inc	Stabilized human papillomavirus formulations
PL347472A1 (en) *	1998-08-14	2002-04-08	Merck & Co Inc	Process for purifying human papillomavirus virus-like particles
DE19840263C1 (de) *	1998-09-03	2000-05-25	Deutsches Krebsforsch	Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en)	1998-11-23	2002-04-30	Loyola University Of Chicago	Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en)	1998-12-11	1999-01-14	University Of Queensland, The	Treatment of papillomavirus infections
KR20010093290A (ko)	1999-02-05	2001-10-27	폴락 돈나 엘.	사람 파필로마바이러스 백신 제제
US7001995B1 (en) *	1999-08-25	2006-02-21	Merck & Co., Inc.	Synthetic human papillomavirus genes
SI1421200T1 (sl) *	2001-08-23	2007-04-30	Merck & Co Inc	Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (fr) *	2001-10-10	2003-04-16	King Car Food Industrial Co., Ltd.	Procédé et détecteur pour la détection de virus de type de HPV
BRPI0407877A (pt) *	2003-03-07	2006-03-01	Merck & Co Inc	conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente
ES2381964T3 (es) *	2003-03-24	2012-06-04	Merck Sharp & Dohme Corp.	Expresión optimizada de L1 de VPH 31 en levadura
IL156670A0 (en) *	2003-06-26	2004-01-04	Zvi Zolotariov	Aloe suppositories
JP4498357B2 (ja)	2003-09-25	2010-07-07	サード・ウェーブ・テクノロジーズ・インク	Ｈｐｖの検出法
MY140664A (en) *	2003-09-29	2010-01-15	Merck Sharp & Dohme	Optimized expression of hpv 45 l1 in yeast
MY139500A (en) *	2003-11-12	2009-10-30	Merck Sharp & Dohme	Optimized expression of hpv 58 l1 in yeast
BRPI0509079B8 (pt) *	2004-03-24	2021-07-06	Merck & Co Inc	molécula de ácido nucléico, vetor, célula hospedeira, partículas tipo vírus, método para produzir vlps, vacina, composições farmacêuticas, e, métodos para evitar infecção por hpv e para induzir uma resposta imune em um animal
WO2006063065A2 (fr)	2004-12-08	2006-06-15	Gen-Probe Incorporated	Detection d'acides nucleiques de types multiples de papillomavirus humains
CN101341257B (zh) *	2004-12-10	2012-10-10	杰纳罗生物系统有限责任公司	使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
KR20080084809A (ko) *	2005-11-15	2008-09-19	게노이드 케이에프티.	병원체를 검출하는 방법
US8080643B2 (en) *	2006-09-05	2011-12-20	Third Wave Technologies, Inc.	HPV primers
KR20090073987A (ko) *	2007-12-31	2009-07-03	정운원	인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
CA2799205A1 (fr)	2010-05-25	2011-12-01	Qiagen Gaithersburg, Inc.	Analyse de capture hybride a resultats rapides et sondes associees tronquees de maniere strategique
EP2638058B1 (fr)	2010-11-12	2017-01-11	Merck Sharp & Dohme Corp.	Enolase peptidiques vaccins conjugues contre staphylococcus aureus
CN103717741B (zh)	2011-06-15	2016-04-13	中央大学校产学协力团	用于提高人乳头瘤病毒l1蛋白产量的方法
US10513541B2 (en)	2015-12-04	2019-12-24	Xiamen University	Mutant of L1 protein of human papillomavirus type 11
JP7290258B2 (ja) *	2018-09-26	2023-06-13	厦▲門▼大学	ヒトパピローマウイルス５１型のｌ１タンパク質の変異型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69233639T2 (de) *	1991-07-19	2007-05-31	Csl Ltd., Parkville	Polynukleotidabschnitt des HPV16-Genoms
ATE296111T1 (de) *	1993-03-09	2005-06-15	Univ Rochester	Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen

1996
- 1996-03-21 IL IL11759196A patent/IL117591A0/xx not_active IP Right Cessation
- 1996-03-26 EP EP96912467A patent/EP0817852B1/fr not_active Expired - Lifetime
- 1996-03-26 JP JP52959696A patent/JP3918877B2/ja not_active Expired - Lifetime
- 1996-03-26 AU AU55277/96A patent/AU708111B2/en not_active Expired
- 1996-03-26 CZ CZ19973091A patent/CZ291375B6/cs not_active IP Right Cessation
- 1996-03-26 ES ES96912467T patent/ES2203691T3/es not_active Expired - Lifetime
- 1996-03-26 PL PL96322588A patent/PL183299B1/pl unknown
- 1996-03-26 CN CNB961941960A patent/CN1154732C/zh not_active Expired - Lifetime
- 1996-03-26 PT PT96912467T patent/PT817852E/pt unknown
- 1996-03-26 DK DK96912467T patent/DK0817852T3/da active
- 1996-03-26 EA EA199700281A patent/EA000969B1/ru not_active IP Right Cessation
- 1996-03-26 NZ NZ306663A patent/NZ306663A/en not_active IP Right Cessation
- 1996-03-26 WO PCT/US1996/004117 patent/WO1996030520A2/fr not_active Ceased
- 1996-03-26 HU HU9801608A patent/HU228490B1/hu unknown
- 1996-03-26 SK SK1293-97A patent/SK283998B6/sk not_active IP Right Cessation
- 1996-03-26 AT AT96912467T patent/ATE247712T1/de active
- 1996-03-26 US US08/913,462 patent/US6159729A/en not_active Expired - Lifetime
- 1996-03-26 KR KR1019970706796A patent/KR100441477B1/ko not_active Expired - Lifetime
- 1996-03-26 DE DE69629556T patent/DE69629556T2/de not_active Expired - Lifetime
- 1996-03-29 ZA ZA962526A patent/ZA962526B/xx unknown
1997
- 1997-09-29 NO NO19974514A patent/NO320086B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1996030520A3 (fr)	1996-11-07
EA000969B1 (ru)	2000-08-28
NO974514D0 (no)	1997-09-29
PT817852E (pt)	2003-12-31
CZ291375B6 (cs)	2003-02-12
HU228490B1 (en)	2013-03-28
AU708111B2 (en)	1999-07-29
PL183299B1 (pl)	2002-06-28
PL322588A1 (en)	1998-02-02
EA199700281A1 (ru)	1998-04-30
ATE247712T1 (de)	2003-09-15
EP0817852B1 (fr)	2003-08-20
WO1996030520A2 (fr)	1996-10-03
HUP9801608A2 (hu)	1998-10-28
JP3918877B2 (ja)	2007-05-23
ZA962526B (en)	1996-09-04
CN1154732C (zh)	2004-06-23
NO974514L (no)	1997-11-27
EP0817852A2 (fr)	1998-01-14
SK129397A3 (en)	1998-05-06
HUP9801608A3 (en)	1999-04-28
ES2203691T3 (es)	2004-04-16
JPH11503313A (ja)	1999-03-26
AU5527796A (en)	1996-10-16
KR100441477B1 (ko)	2004-10-06
NO320086B1 (no)	2005-10-24
SK283998B6 (sk)	2004-07-07
CN1185810A (zh)	1998-06-24
NZ306663A (en)	1999-10-28
DE69629556T2 (de)	2004-06-17
DE69629556D1 (de)	2003-09-25
CZ309197A3 (cs)	1998-02-18
KR19980703391A (ko)	1998-10-15
US6159729A (en)	2000-12-12
IL117591A0 (en)	1996-07-23

Publication	Publication Date	Title
NO974514L (no)	1997-11-27	Syntetisk HPV6/11 hybrid L1 DNA som koder for humant papillomavirus Type 11 L1-protein
NL300273I1 (nl)	2007-05-01	DNA dat humaan papillomavirus type 18 codeert.
HUP9802556A1 (hu)	1999-03-29	Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
BG100974A (en)	1998-04-30	Vaccines against papillomavirus
BG102616A (en)	1999-04-30	Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
EP0982988A4 (fr)	2000-04-05	Zonuline pratiquement pure, modulateur physiologique des jonctions serrees mammaliennes
AR038429A2 (es)	2005-01-12	Compuestos 15-alquil-16-hidroxilo de marcfortina
ATE198624T1 (de)	2001-01-15	Expression von albumin in hefe
TR199900501T2 (xx)	1999-07-21	Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
IL122606A (en)	2005-11-20	(S)-hydroxa-nitrile-lyase
EP0477200A4 (fr)	1992-02-11	Purification de proteines utilisant des fusions ctap-iii.
ATE161713T1 (de)	1998-01-15	Feuchtigkeitsspender
DE69917445D1 (de)	2004-06-24	Reinigung von carboxaldehyd
IT1277391B1 (it)	1997-11-10	Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
MX9707457A (es)	1998-01-31	Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ES2097368T3 (es)	1997-04-01	Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
SE9501512D0 (sv)	1995-04-24	Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
DK0891322T3 (da)	2001-01-29	Dimethylsubstituerede cyclohexandienderivater
DE59611353D1 (de)	2006-07-06	Transketolase-verwandtes protein
CA2216827A1 (fr)	1996-10-03	Adn de synthese hybride hpv6/11 l1 codant pour des proteines de papillomavirus humain de type 11 l1
ES2191785T3 (es)	2003-09-16	Proteina de accion antitumoral.
MX9702209A (es)	1997-07-31	Dna que codifica para virus de papiloma humano tipo 6a.
NO982151L (no)	1998-07-03	Hemoregulatoriske forbindelser
BR9705217C2 (pt)	2000-05-02	Registro de datas em seis digitos até 31/c/z99.